Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ostrega, D.
Right arrow Articles by Hales, C. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ostrega, D.
Right arrow Articles by Hales, C. N.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes, Vol 44, Issue 4 437-440, Copyright © 1995 by American Diabetes Association

ARTICLES

Measurement of proinsulin and intermediates. Validation of immunoassay methods by high-performance liquid chromatography

D Ostrega, K Polonsky, D Nagi, J Yudkin, LJ Cox, PM Clark and CN Hales
Section of Endocrinology, University of Chicago Medical Center, Illinois.

Human proinsulin and 32-33 split proinsulin have been measured in the peripheral circulation by immunoradiometric assays (IRMAs) and have been shown to be elevated in impaired glucose tolerance and non-insulin-dependent diabetes mellitus (NIDDM). The IRMA for 32-33 split proinsulin did not discriminate between this molecule and des-32 or des-31,32 split proinsulin. We describe the comparison of IRMA for human plasma proinsulin and 32-33 split proinsulins with assays combined with high-performance liquid chromatography (HPLC), which can discriminate between 32-33 split, des-32 split, and des-31,32 split proinsulin. Subjects were those with normal glucose tolerance (n = 8) and those with NIDDM (n = 17), who were studied while fasting and 30 min after a glucose load. After collection, blood was centrifuged promptly, and the serum/plasma was stored frozen until assay. Both IRMA and HPLC methods were calibrated against synthetic peptides. Interassay coefficients of variation for the IRMA for proinsulin and 32-33 split proinsulin were < 13% over the ranges 3.8-65 pmol/l and 6.4-65 pmol/l, respectively. The following regression lines were obtained: proinsulin IRMA = -0.143 + 1.066 HPLC, r = 0.860; 32-33 split proinsulin IRMA = 0.048 + 1.051 HPLC; and des-31,32 split proinsulin, r = 0.814. For both analytes, there was no significant difference in the relationship of IRMA to HPLC results between the various subject groups and various time points. Thus, the IRMA for proinsulin has been validated by an independent method.(ABSTRACT TRUNCATED AT 250 WORDS)
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 DiabetesHome page
A. Festa, K. Williams, A. J.G. Hanley, and S. M. Haffner
{beta}-Cell Dysfunction in Subjects With Impaired Glucose Tolerance and Early Type 2 Diabetes: Comparison of Surrogate Markers With First-Phase Insulin Secretion From an Intravenous Glucose Tolerance Test
Diabetes, June 1, 2008; 57(6): 1638 - 1644.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
S. Marcovina, R. R. Bowsher, W. G. Miller, M. Staten, G. Myers, S. P. Caudill, S. E. Campbell, M. W. Steffes, and for the Insulin Standardization Workgroup
Standardization of Insulin Immunoassays: Report of the American Diabetes Association Workgroup
Clin. Chem., April 1, 2007; 53(4): 711 - 716.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
R. S. Lindsay, J. D. Walker, I. Halsall, C. N. Hales, A. A. Calder, B. A. Hamilton, and F. D. Johnstone
Insulin and Insulin Propeptides at Birth in Offspring of Diabetic Mothers
J. Clin. Endocrinol. Metab., April 1, 2003; 88(4): 1664 - 1671.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
A. Festa, R. D'Agostino Jr, L. Mykkanen, R. P. Tracy, D. J. Zaccaro, C. N. Hales, and S. M. Haffner
Relative Contribution of Insulin and Its Precursors to Fibrinogen and PAI-1 in a Large Population With Different States of Glucose Tolerance : The Insulin Resistance Atherosclerosis Study (IRAS)
Arterioscler. Thromb. Vasc. Biol., March 1, 1999; 19(3): 562 - 568.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
S. M. Haffner, R. D'Agostino Jr, L. Mykkanen, C. N. Hales, P. J. Savage, R. N. Bergman, D. O'Leary, M. Rewers, J. Selby, R. Tracy, et al.
Proinsulin and Insulin Concentrations in Relation to Carotid Wall Thickness : Insulin Resistance Atherosclerosis Study
Stroke, August 1, 1998; 29(8): 1498 - 1503.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Furuta, R. Carroll, S. Martin, H. H. Swift, M. Ravazzola, L. Orci, and D. F. Steiner
Incomplete Processing of Proinsulin to Insulin Accompanied by Elevation of Des-31,32 Proinsulin Intermediates in Islets of Mice Lacking Active PC2
J. Biol. Chem., February 6, 1998; 273(6): 3431 - 3437.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
O. Varlamov, L. D. Fricker, H. Furukawa, D. F. Steiner, S. H. Langley, and E. H. Leiter
{beta}-Cell Lines Derived from Transgenic Cpefat/Cpefat Mice Are Defective in Carboxypeptidase E and Proinsulin Processing
Endocrinology, November 1, 1997; 138(11): 4883 - 4892.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. G. Warren-Perry, S. E. Manley, D. Ostrega, K. Polonsky, S. Mussett, P. Brown, and R. C. Turner
A Novel Point Mutation in the Insulin Gene Giving Rise to Hyperproinsulinemia
J. Clin. Endocrinol. Metab., May 1, 1997; 82(5): 1629 - 1631.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 1995 by the American Diabetes Association.